プラズマにおけるチゲシクリン,メロペネム,ポリミキシンBの同時定量と,HSCT患者におけるタンパク質結合分析
Yan Gong1, Weijing Gong1, Junmiao Chen2
1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Bioanalysis
|August 25, 2025
まとめ
新しいUPLC-MS/MSメソッドは,HSCT患者のチゲサイクリン,メロペネム,ポリミキシンBを正確に定量化します. 抗生物質のタンパク質結合は変化し,CREに感染した患者のBMIとアルバミンが潜在的に影響する.
科学分野:
- 薬理学と薬物モニタリング
- 分析化学
- 血液学と幹細胞移植
背景:
- 血液形成幹細胞移植 (HSCT) の患者は,感染のリスクが高いため,しばしば広範囲の抗生物質を必要とします.
- 免疫低下患者の治療を最適化するために,ティゲサイクリン,メロペネム,ポリミキシンBなどの抗生物質の正確な定量化が不可欠です.
- 薬剤とタンパク質の結合を理解することは,薬理学的なデータを解釈し,投与量を調整するために不可欠です.
研究 の 目的:
- ヒトの血におけるチゲサイクリン,メロペネム,ポリミキシンBの同時定量化のためのUPLC-MS/MS方法を確立し,検証する.
- HSCT患者におけるこれらの抗生物質の未結合分子を決定する.
- 標的集団におけるこれらの抗生物質のタンパク質結合に影響を与える要因を調査する.
主な方法:
- ヒトの血におけるチゲサイクリン,メロペネム,ポリミキシンB1,ポリミキシンB2に対するUPLC-MS/MS測定法の開発と検証
- 検証されたUPLC-MS/MS方法を用いて,HSCT患者の血サンプルを分析する.
- 異なる濃度点でのタンパク質結合率の決定 (低谷とピーク).
主要な成果:
- UPLC-MS/MSメソッドは,ターゲット抗生物質の定量化において高い精度,精度,および安定性を示した.
- 重要なタンパク質結合が観察された: ティゲサイクリン (82. 4%),ポリミキシンB1 (79. 3% - 83. 7%),およびポリミキシンB2 (82. 6% - 86. 7%)
- タンパク質結合は通常,ピーク濃度と比較して最低濃度で低かった.
結論:
- 検証されたUPLC-MS/MS方法は,HSCT患者のチゲサイクリン,メロペネム,ポリミキシンBの治療薬モニタリングのための信頼できるツールを提供します.
- 抗生物質のタンパク質結合は,この患者群ではかなり濃度に依存しています.
- Carbapenem 耐性 Enterobacteriaceae 感染した HSCT 患者の体量指数と血清 アルブミンは,ポリミキシン B 結合に影響を及ぼし,より大きなコホートでのさらなる調査を正当化することが示唆されています.
さらに関連する動画
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.0K
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.0K
関連する概念動画
01:19Restorative Care
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
01:25Continuing Care
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
01:24Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data from the...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data from the...
01:29Documentation in Long-Term and Home Healthcare Setting
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.